2 completed, 2 not yet recruiting, 2 recruiting, 2 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 2, Not yet recruiting 2, Recruiting 2, Unknown 2 |
Follow letermovir: new trials by email Literature Review of letermovir trials Research Report on letermovir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letermovir for R+ Study Letermovir - Kidney Transplant, Liver Transplant | Phase 4 | Not yet recruiting | University of Wisconsin, Madison | 146 | 2026-11-01 | 2026-11-19 |
| Letermovir vs Valganciclovir in CMV R+ Kidney Transplant Letermovir, Valganciclovir CMV Prophylaxis - CMV Infection, CMV | Phase 4 | Not yet recruiting | Elisabeth Kincaide | 300 | 2026-05-01 | 2026-05-08 |
| Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients Letermovir, Placebo, Valganciclovir/Ganciclovir - CMV, Lung Transplant Recipient | Phase 4 | Recruiting | University Health Network, Toronto | 40 | 2025-12-24 | 2026-02-17 |
| Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients Letermovir, Valganciclovir - Kidney Transplant | Phase 4 | Recruiting | First Affiliated Hospital Xi'an Jiaotong University | 290 | 2025-05-13 | 2025-12-05 |
| Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT Letermovir for secondary prophylaxis - To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation | Phase 4 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 31 | 2023-07-01 | 2023-06-22 |
| Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT Letermovir - The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation | Phase 4 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 21 | 2023-07-01 | 2023-06-22 |
| Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Letermovir - Cytomegalovirus Infections, Infection in Solid Organ Transplant Recipients | Phase 4 | Completed | Tufts Medical Center | 21 | 2023-02-02 | 2026-10-26 |
| Letermovir Use in Heart Transplant Recipients Letermovir - Cytomegalovirus Disease, Cytomegalovirus Infections | Phase 4 | Completed | Tufts Medical Center | 32 | 2022-01-05 | 2025-07-29 |
Cytomegalovirus Infections (4) · Neutropenia (3)
Institute of Hematology & Blood Diseases Hospital, China (2) · Tufts Medical Center (2) · Elisabeth Kincaide (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · University Health Network, Toronto (1) · University of Wisconsin, Madison (1)
United States (4) · Canada (1) · China (1)
David Al-Adra, MD (1) · Jennifer K Chow, MD, MS (1)